EligibleTrials

A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis

Recruiting · NCT07260669 · Interventional (participants receive a specific treatment) · Lead sponsor: Gesynta Pharma AB

View the official record on ClinicalTrials.gov →
Endometriosis

Interventions studied

PlaceboVipoglanstat

What this trial is about

The main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).

Who can take part

Age range
18 Years to 44 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

44 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.